FDA approves Exactech's distribution of InterSpace Shoulder for arthroplasty

By Lisa Kerner

Charlotte, N.C., June 19 - The Food and Drug Administration approved Exactech, Inc.'s U.S. distribution of a pre-formed cement shoulder spacer containing antibiotic.

The InterSpace Shoulder is designed for treating infected total shoulder arthroplasty.

Like the InterSpace Hip and InterSpace Knee, InterSpace Shoulder releases antibiotic uniformly into the local infected area, maintains the joint space and offers patients mobility.

"The InterSpace shoulder complements the Equinoxe shoulder system, allowing us to meet a wide range of challenges in shoulder reconstruction," said Lynn Crosby, shoulder surgeon and evaluator of the InterSpace Shoulder, in a company news release.

InterSpace is manufactured by Italy-based Tecres SpA and distributed in the United States exclusively by Exactech.

Located in Gainesville, Fla., Exactech develops and markets orthopedic implant devices, related surgical instruments, biologic materials and services to hospitals and physicians.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.